Elevance Health Inc

For the period ended Mar 31, 2025. Filed Apr 22, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed Apr 22, 2025

ELV$429.65+2.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets as of (Unaudited) and December 31,

Consolidated Balance Sheets

	March 31,2025	December 31,2024
(Unaudited)
(In millions, except share and per share data)
Assets
Current assets:
Cash and cash equivalents	$7,500	$8,288
Fixed maturity securities (amortized cost of $25,813 and $25,879; allowance for credit losses of $7 and $6)	25,437	25,201
Equity securities	715	1,192
Premium receivables	10,359	8,011
Self-funded receivables	5,246	5,044
Other receivables	6,576	6,016
Other current assets	5,288	4,700
Assets held for sale	—	490
Total current assets	61,121	58,942
Long-term investments:
Fixed maturity securities (amortized cost of $1,070 and $1,049; allowance for credit losses of $0 and $0)	1,060	1,035
Other invested assets	10,167	9,749
Property and equipment, net	4,617	4,652
Goodwill	28,420	28,277
Other intangible assets	11,940	12,094
Other noncurrent assets	2,392	2,140
Total assets	$119,717	$116,889
Liabilities and equity
Liabilities
Current liabilities:
Medical claims payable	$16,812	$15,746
Other policyholder liabilities	3,796	4,204
Unearned income	1,640	1,508
Accounts payable and accrued expenses	7,131	6,927
Short-term borrowings	250	365
Current portion of long-term debt	1,643	1,649
Other current liabilities	11,426	10,029
Liabilities held for sale	—	153
Total current liabilities	42,698	40,581
Long-term debt, less current portion	28,110	29,218
Reserves for future policy benefits	174	190
Deferred tax liabilities, net	2,121	2,148
Other noncurrent liabilities	3,994	3,326
Total liabilities	77,097	75,463
Shareholders’ equity
Preferred stock, without par value, shares authorized – 100,000,000; shares issued and outstanding – none	—	—
Common stock, par value $0.01, shares authorized – 900,000,000; shares issued and outstanding – 225,641,361 and 227,479,695	2	2
Additional paid-in capital	8,866	8,911
Retained earnings	34,546	33,549
Accumulated other comprehensive loss	(911)	(1,147)
Total shareholders’ equity	42,503	41,315
Noncontrolling interests	117	111
Total equity	42,620	41,426
Total liabilities and equity	$119,717	$116,889

-2-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.